Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 3:59 pm Sale | 13G | INFINITY PHARMACEUTICALS INC C INFI | Polar Capital Holdings Plc | 2,071,242 2.3% | -2,928,758 (-58.58%) | View |
| 2023-02-09 11:22 am Sale | 13G | INFINITY PHARMACEUTICALS INC C INFI | VANGUARD GROUP INC | 5,313,679 5.95% | -469,754 (-8.12%) | View |
| 2022-07-08 4:56 pm Sale | 13G | INFINITY PHARMACEUTICALS INC C INFI | BlackRock Inc. BLK | 2,305,486 2.6% | -4,362,017 (-65.42%) | View |
| 2022-02-14 2:01 pm Sale | 13G | INFINITY PHARMACEUTICALS INC C INFI | BIOTECHNOLOGY VALUE FUND L P | 6,353,645 7.1% | -2,030,000 (-24.21%) | View |
| 2022-02-14 1:38 pm Sale | 13G | INFINITY PHARMACEUTICALS INC C INFI | EcoR1 Capital LLC | 0 0% | -4,368,500 (Position Closed) | View |
| 2022-02-14 10:41 am Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | Polar Capital Holdings Plc | 5,000,000 5.6% | 5,000,000 (New Position) | View |
| 2022-02-10 08:17 am Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | VANGUARD GROUP INC | 5,783,433 6.5% | 3,888,514 (+205.21%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | BlackRock Inc. BLK | 6,667,503 7.5% | 5,754,043 (+629.92%) | View |
| 2022-01-18 4:12 pm Sale | 13G | INFINITY PHARMACEUTICALS INC C INFI | INTEGRATED CORE STRATEGIES (US) LLC | 743,271 0.8% | -4,319,036 (-85.32%) | View |
| 2021-06-17 4:16 pm Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | INTEGRATED CORE STRATEGIES (US) LLC | 5,062,307 5.7% | 5,062,307 (New Position) | View |
| 2021-02-19 5:10 pm Unchanged | 13G | INFINITY PHARMACEUTICALS INC C INFI | BIOTECHNOLOGY VALUE FUND L P | 8,383,645 9.96% | 0 (Unchanged) | View |
| 2021-02-16 4:30 pm Sale | 13D | INFINITY PHARMACEUTICALS INC C INFI | BIOTECHNOLOGY VALUE FUND L P | 8,383,645 13.1% | -2,343,323 (-21.85%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | Opaleye Management Inc. | 3,171,800 4.94% | 171,400 (+5.71%) | View |
| 2021-01-26 5:26 pm Sale | 13D | INFINITY PHARMACEUTICALS INC C INFI | BIOTECHNOLOGY VALUE FUND L P | 10,726,968 16.7% | -6,700,000 (-38.45%) | View |
| 2021-01-26 12:21 pm Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | EcoR1 Capital LLC | 4,368,500 6.8% | 4,368,500 (New Position) | View |
| 2020-11-12 5:13 pm Unchanged | 13D | INFINITY PHARMACEUTICALS INC C INFI | BIOTECHNOLOGY VALUE FUND L P | 17,426,968 27.1% | 0 (Unchanged) | View |
| 2020-09-18 6:48 pm Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | Opaleye Management Inc. | 3,000,400 5.1% | 3,000,400 (New Position) | View |
| 2020-01-10 5:22 pm Purchase | 13D | INFINITY PHARMACEUTICALS INC C INFI | BIOTECHNOLOGY VALUE FUND L P | 17,426,968 30.6% | 275,000 (+1.60%) | View |